EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Did the French pregnancy pictogram change antiseizure medication use during pregnancy?

Mélanie Araujo iD, Christine Damase-Michel iD, Marie Denuelle iD, Sébastien Boulogne iD, Laurane Delteil iD, Monica Saucedo iD, Catherine Deneux-Tharaux iD, Isabelle Lacroix iD

Epilepsia · 2026-06 · 67 (6) · 2864-2874

DOI: 10.1002/epi.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 09.03.2026. Verfasst von Mélanie Araujo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Médecine de Toulouse, Centre Hospitalier Universitaire de Toulouse, Institut National de la Santé et de la Recherche Médicale (INSERM) Uni…. Hauptthemen laut MEDLINE: Anticonvulsants, Pregnancy Complications, Epilepsy, Drug Labeling. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPI-PHARE, ANSM (French National Agency for the Safety of Medicines and Health Products), CNAM (French National Health Insurance Fund).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to assess the impact of introducing a pregnancy pictogram on medication packaging on the prescription and dispensation of antiseizure medications and on the maternal and neonatal outcomes for women exposed to these medications.

Methods

This is a national retrospective cohort study, based on the French National Health Data System, with a “before/after the introduction of the pictogram” design. Women aged between 15 and 55 years who had a pregnancy outcome between 2014 and 2017 (“before pictogram” period) and between 2018 and 2021 (“after pictogram” period) and who had received at least two antiseizure medication dispensations before their pregnancy were included. We compared the rates of antiseizure medication discontinuation and continuation during pregnancy, the average doses used, and maternal and neonatal outcomes between the two periods.

Results

The rate of women who had received at least two dispensations of a medication indicated for epilepsy before their pregnancy remained stable between the two periods (.7%). There was a significant decrease in valproic acid prescriptions (5.4% vs. 1.3%) during pregnancy and, conversely, an increase in lamotrigine (29.9% vs. 31.5%) and levetiracetam (10.9% vs. 14.5%) prescriptions. Prescriptions by specialists such as neurologists increased significantly (22.8% vs. 28%) between the two periods. There was an increase of more than 2.7% in the continuation of antiseizure medication (37.6% vs. 40.3%, p < .0001) and conversely a decrease in the rate of women who stopped their antiseizure treatment before or during pregnancy in the “after pictogram” period (59.4% vs. 56.7%, p < .0001). Rates of maternal and neonatal outcomes remained similar between the two periods. Significance The introduction of a pregnancy pictogram in France in 2017 was not associated with an increase in discontinuation of antiseizure medications, less adequate treatment, or poorer maternal or neonatal outcomes in pregnant women receiving these medications before pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsPregnancy ComplicationsEpilepsyDrug LabelingHumansFemalePregnancyFranceAdultRetrospective StudiesYoung AdultAdolescentPregnancy OutcomeMiddle AgedLevetiracetamValproic AcidLamotrigine

Stichwörter der Autor:innen

SNDS databaseantiseizure medicationsimpact studypictogrampregnancy

Substanzen

AnticonvulsantsLevetiracetamValproic AcidLamotrigine

Autor:innen und Institutionen

  • Faculté de Médecine de Toulouse, Centre Hospitalier Universitaire de Toulouse, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1295, Toulouse, France.
  • Electrophysiologie Cérébrale, Épilepsie et Sommeil, Hôpital Pierre Paul Riquet, CHU Purpan, Toulouse, France.
  • Service de Neurologie Fonctionnelle et d'épileptologie, Groupement Hospitalier Est-Hôpital Pierre Wertheimer, Bron, France.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Center for Research in Epidemiology and Statistics, Obste…

ORCID-Profile: Mélanie Araujo, Christine Damase-Michel, Marie Denuelle, Sébastien Boulogne, Laurane Delteil, Monica Saucedo, Catherine Deneux-Tharaux, Isabelle Lacroix

Förderung

  • EPI-PHARE
  • ANSM (French National Agency for the Safety of Medicines and Health Products)
  • CNAM (French National Health Insurance Fund)
  • Agence Nationale de Sécurité du Médicament et des Produits de Santé
  • Caisse nationale de l'Assurance Maladie

Zitieren

APA

Araujo, M., Damase-Michel, C., Denuelle, M., Boulogne, S., Delteil, L., Saucedo, M., Deneux-Tharaux, C., & Lacroix, I. (2026). Did the French pregnancy pictogram change antiseizure medication use during pregnancy?. Epilepsia, 67(6), 2864-2874. https://doi.org/10.1002/epi.70163

Vancouver

Araujo M, Damase-Michel C, Denuelle M, Boulogne S, Delteil L, Saucedo M, et al. Did the French pregnancy pictogram change antiseizure medication use during pregnancy?. Epilepsia. 2026;67(6):2864-2874. doi:10.1002/epi.70163

BibTeX
@article{Araujo2026,
  author = {Araujo, Mélanie and Damase-Michel, Christine and Denuelle, Marie and Boulogne, Sébastien and Delteil, Laurane and Saucedo, Monica and Deneux-Tharaux, Catherine and Lacroix, Isabelle},
  title = {Did the French pregnancy pictogram change antiseizure medication use during pregnancy?},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {2864--2874},
  doi = {10.1002/epi.70163}
}
Kostenlos starten →